UBS analyst Luiz Carvalho downgrades Ecopetrol (NYSE:EC) from Buy to Neutral.
Qualigen Therapeutics’ Novel Direct Pan-RAS Inhibitors Presented At American Association Of Cancer Research 2024 Annual Meeting
Poster Includes Preclinical Data on Novel Direct Pan-RAS InhibitorsCARLSBAD, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (("Qualigen" or "the Company, NASDAQ:QLGN) today announces a poster